scispace - formally typeset
Open AccessJournal ArticleDOI

The proximal origin of SARS-CoV-2.

Reads0
Chats0
TLDR
It is shown that SARS-CoV-2 is not a laboratory construct or a purposefully manipulated virus, and scenarios by which they could have arisen are discussed.
Abstract
SARS-CoV-2 is the seventh coronavirus known to infect humans; SARSCoV, MERS-CoV and SARS-CoV-2 can cause severe disease, whereas HKU1, NL63, OC43 and 229E are associated with mild symptoms6. Here we review what can be deduced about the origin of SARS-CoV-2 from comparative analysis of genomic data. We offer a perspective on the notable features of the SARS-CoV-2 genome and discuss scenarios by which they could have arisen. Our analyses clearly show that SARS-CoV-2 is not a laboratory construct or a purposefully manipulated virus.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Identification of potential SARS-CoV-2 inhibitors from South African medicinal plant extracts using molecular modelling approaches.

TL;DR: Four bioactive compounds isolated from commonly used South African medicinal plants exhibited favourable binding orientations characterized by strong molecular interactions within respective inhibitors binding pockets of the target enzymes, which could serve as a starting point for the discovery of novel SARS-CoV-2 therapeutic agents.
Journal ArticleDOI

The human coronaviruses (HCoVs) and the molecular mechanisms of SARS-CoV-2 infection.

TL;DR: The main knowledge the authors have about the biomolecular and pathophysiologic mechanisms of SARS-CoV-2 is highlighted.
Journal ArticleDOI

Repositioning Ivermectin for Covid-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replication

TL;DR: Ivermectin (IVM) is an FDA approved macrocyclic lactone compound traditionally used to treat parasitic infestations and has shown to have antiviral potential from previous in-vitro studies as discussed by the authors .
Journal ArticleDOI

A benchmarking study of SARS-CoV-2 whole-genome sequencing protocols using COVID-19 patient samples.

TL;DR: In this paper, the authors compared seven different SARS-CoV-2 WGS library protocols using RNA from patient nasopharyngeal swab samples under two storage conditions with low and high viral inputs.
Journal ArticleDOI

A new era for the therapeutic management of the ongoing COVID-19 pandemic

TL;DR: The present study is reviewing the background of human coronaviruses, the potential viral reservoirs, the main genomic and pathogenic aspects of SARS-CoV-2 and the actual data on the immunopathological mechanisms of COVID 19, looking towards therapeutic approaches for SARS -CoV2 infection.
References
More filters
Journal ArticleDOI

A pneumonia outbreak associated with a new coronavirus of probable bat origin

TL;DR: Identification and characterization of a new coronavirus (2019-nCoV), which caused an epidemic of acute respiratory syndrome in humans in Wuhan, China, and it is shown that this virus belongs to the species of SARSr-CoV, indicates that the virus is related to a bat coronav virus.
Journal ArticleDOI

A new coronavirus associated with human respiratory disease in China.

TL;DR: Phylogenetic and metagenomic analyses of the complete viral genome of a new coronavirus from the family Coronaviridae reveal that the virus is closely related to a group of SARS-like coronaviruses found in bats in China.
Journal ArticleDOI

An interactive web-based dashboard to track COVID-19 in real time.

TL;DR: The outbreak of the 2019 novel coronavirus disease (COVID-19) has induced a considerable degree of fear, emotional stress and anxiety among individuals around the world.
Journal ArticleDOI

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.

TL;DR: The authors show that this protein binds at least 10 times more tightly than the corresponding spike protein of severe acute respiratory syndrome (SARS)–CoV to their common host cell receptor, and test several published SARS-CoV RBD-specific monoclonal antibodies found that they do not have appreciable binding to 2019-nCoV S, suggesting that antibody cross-reactivity may be limited between the two RBDs.
Related Papers (5)